Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.14.5617

Analysis of Different Ways of Drainage for Obstructive Jaundice Caused by Hilar Cholangiocarcinoma  

Xu, Chuan (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Lv, Peng-Hua (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Huang, Xin-En (Department of Chemotherapy, Jiangsu Cancer Hospital & Institute of Cancer Research, Nanjing Medical University)
Wang, Shu-Xiang (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Sun, Ling (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Wang, Fu-An (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.14, 2014 , pp. 5617-5620 More about this Journal
Abstract
Objective: To evaluate the prognosis of different ways of drainage for patients with obstructive jaundice caused by hilar cholangiocarcinoma. Materials and Methods: During the period of January 2006- March 2012, percutaneous transhepatic catheter drainage (PTCD)/ percutaneous transhepatic biliary stenting (PTBS) were performed for 89 patients. According to percutaneous transhepatic cholangiography (PTC), external drainage was selected if the region of obstruction could not be passed by guide wire or a metallic stent was inserted if it could. External drainage was the first choice if infection was diagnosed before the procedure, and a metallic stent was inserted in one week after the infection was under control. Selection by new infections, the degree of bilirubin decrease, the change of ALT, the time of recurrence of obstruction, and the survival time of patients as the parameters was conducted to evaluate the methods of different interventional treatments regarding prognosis of patients with hilar obstruction caused by hilar cholangiocarcinoma. Results: PTCD was conducted in 6 patients and PTBS in 7 (p<0.05). Reduction of bilirubin levels and ALT levels was obvious after the procedures (p<0.05). The average survival time with PTCD was 161 days and with PTBS was 243 days (p<0.05). Conclusions: With both drainage procedures for obstructive jaundice caused by hilar cholangiocarcinoma improvement in liver function was obvious. PTBS was found to be better than PTCD for prolonging the patient survival.
Keywords
Cholangiocarcinoma; hilar obstruction; jaundice; stent; the external drainage; biliary infection;
Citations & Related Records
Times Cited By KSCI : 16  (Citation Analysis)
연도 인용수 순위
1 Butthongkomvong K, Sirachainan E, Jhankumpha S, et al(2013). Treatment outcome of palliative chemotherapy in inoperable cholangiocarcinoma in Thailand. Asian Pac J Cancer Prev. 14, 3565-8.   과학기술학회마을   DOI   ScienceOn
2 Born P, Rosch T, Bruhi K et al (1998). Long-term results of endoscopic treatment of biliary duct obstruction due topancreatic disease. Hepatogastroenterology, 45, 833-9
3 Burke DR, Lewis CA, Cardella JF, et al (2003). Qualityimprovement guidelines for percutaneous transhepaticcholagiography and biliary, J Vasc Interv radiol, 14, 243-6.
4 Chong RJ, Abdullah MS, Hossain MM, et al (2013). Risingincidence of primary liver cancer in Brunei Darussalam. Asian Pac J Cancer Prev, 14, 3473-7.   DOI   ScienceOn
5 Simmons DT, Baron TH, Petersen BT, et al (2006). A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am J Gastroenterol, 64, 1792-6.
6 Sriraksa R, Limpaiboon T (2013). Histone deacetylasesand their inhibitors as potential therapeutic drugs forcholangiocarcinoma - cell line findings. Asian Pac J Cancer Prev. 14, 2503-8.   DOI   ScienceOn
7 Srikoon P, Kariya R, Kudo E, et al (2013). Diethyldithiocarbamatesuppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells. Asian Pac J Cancer Prev. 14, 4441-6.   과학기술학회마을   DOI   ScienceOn
8 Subrungruanga I, Thawornkunob C, Chawalitchewinkoon-Petmitrc P, et al (2013). Gene expression profiling of intrahepatic cholangiocarcinoma. Asian Pac J Cancer Prev. 14, 557-63.   과학기술학회마을   DOI   ScienceOn
9 Thunyaharn N, Promthet S, Wiangnon S, et al (2013). Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev. 14, 7029-32.   과학기술학회마을   DOI
10 Dambraukas Z, Paskauskas S, Lizdenis P, et al (2003). Percutaneous transhepatic biliary stenting: the firstexperience and results of the Hospital of Kaunas University of Medicine. Med (Kaunas), 44, 969-976.
11 DA Westwood, C Fernando, Sj Connor, et al (2010). external percutaneous transhepatic billary drainage for malignantbiliary obstruction:a retrospective analysis. J Med Imaging Radiat Oncol, 54, 108-110.   DOI   ScienceOn
12 Duangsong R, Promthet S, Thaewnongiew K (2013). Development of a community-based approach to opisthorchiasis control.Asian Pac J Cancer Prev. 14, 7039-43.   과학기술학회마을   DOI
13 Hatzidakis AA, Testis D, Chrysou E, et al (2001). Nitinolstents for palliative treatment of malignant obstructivejaundice:should we stent the sphincter of Oddi in every case?Cardiovase Intervent Radio, 24, 245-8   DOI
14 He P, Shi JS, Chen WK, et al (2002). Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma. Worlgd J gastroenterol,8, 943-6
15 Huang Q, Liu L, Liu CH, et al (2013). MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and maybe a potential biomarker for cancer prognosis. Asian Pac J Cancer Prev. 14, 829-34.   과학기술학회마을   DOI   ScienceOn
16 Hussain SM, Al-Jashamy KA (2013). Determination of chemicalcomposition of gallbladder stones and their association withinduction of cholangiocarcinoma. Asian Pac J Cancer Prev. 14, 6257-60.   DOI   ScienceOn
17 Ho CS, Warkentin AE (2013). Evidence-based decompression in malignant biliary obstruction. Korean J Radiol, 13, 56-61.
18 Todoroki T (2000). Chemotherapy for bile duct carcinomain the light of adjuvant chemotherapy to surgery. Hepatogastroenterology, 47, 644-649.
19 Woradet S, Promthet S, Songserm N, et al (2013). Factorsaffecting survival time of cholangiocarcinoma patients: a prospective study in Northeast Thailand. Asian Pac J Cancer Prev. 14, 1623-7.   과학기술학회마을   DOI   ScienceOn
20 Xu C, Huang XE, Wang SX et al (2014). Drainage aloneor combined with anti-tumor therapy for treatment ofobstructive jaundice caused by recurrence and metastasisafter primary tumor resection. Asian Pac J Cancer Prev. 15, 2681-4.   DOI   ScienceOn
21 Iruarrizaga E, Azkoma E, Martinez, et al (2011). Percutaneous transhepatic biliary drainage (PTBD) and endoscopicretrograde cholangiopancreatography (ERCP) for malignantobstructive jaundice (OJ) in advanced digestive cancers. J Clinical Oncol, 29, 348.   DOI
22 Kamsa-ard S, Laopaiboon M, Luvira V, et al (2013). Associationbetween praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic reviewand meta-analysis. Asian Pac J Cancer Prev. 14, 7011-6.   과학기술학회마을   DOI
23 Manwong M, Songserm N, Promthet S, et al (2013). Risk factorsfor cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study. Asian Pac J Cancer Prev. 14, 5953-6.   과학기술학회마을   DOI   ScienceOn
24 Qian XJ, Zhai RY, Dai DK, et al (2006). Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. World J gastroenterol, 12, 331-335.
25 Prachayakul V, Chaisayan S, Aswakul P, et al (2013). Clinical characteristics and treatment outcomes of patients withunresectable cholangiocarcinoma in Thailand: are theredifferences dependent on stent type? Asian Pac J Cancer Prev. 14, 529-32.   DOI
26 Saengsawang P, Promthet S, Bradshaw P (2013). Infectionwith Opisthorchis viverrini and use of praziquantel among a working-age population in northeast Thailand. Asian Pac J Cancer Prev. 14, 2963-6.   과학기술학회마을   DOI   ScienceOn
27 Shin Ahn, Yoon-seon Lee, Kyung Soo Lin, et al (2013). Malignant biliary obstructions can we predict immediatepostprocedural cholangitis after percutaneous biliarydrainage? Support Care Cancer, 21, 2321-6.   DOI   ScienceOn
28 Yu Li sol, Chang Won Kim, et al (2010). Early Infectious Complications of Percutaneous Metallic Stent Insertionfor Malignant Biliary Obstruction. AJR Am J Roentgenol,194, 261-5.   DOI
29 E.A.de Jong, A. Moelker, T. Leertouwer, et al (2013).Percutaneous Transhepatic Biliary Drainage in Patients with Postsurgical Bile Leakage and Nondilated Intrahepatic Bile Ducts. Dig Surg, 30, 444-450.   DOI   ScienceOn
30 Sriputtha S, Khuntikeo N, Promthet S, et al (2013). Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev. 14, 1107-10.   과학기술학회마을   DOI   ScienceOn